Kelly MacDonald, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 3,597 shares at $11.63 ($42K) on 2020-02-21, disclosed to the SEC on 2020-02-25.
Scheduled sale ($42k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.63 | 302 | $4K | 8.4% |
| 2 | $11.63 | 303 | $4K | 8.4% |
| 3 | $11.63 | 504 | $6K | 14.0% |
| 4 | $11.63 | 793 | $9K | 22.0% |
| 5 | $11.63 | 1,695 | $20K | 47.1% |
| Total | $11.63 avg | 3,597 |
| $42K |
| 100% |
| Filing → |
| IRWD | SELL | 2020-11-10 | $31K | — | Filing → |
| IRWD | SELL | 2020-10-13 | $238K | — | Filing → |
| IRWD | SELL | 2020-08-19 | $6K | — | Filing → |